Prostate Cancer
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.
August 21, 2023
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
August 21, 2023
Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer.
August 21, 2023
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
August 18, 2023
18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study.
August 18, 2023
SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression.
August 18, 2023
ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.
August 18, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading.
August 17, 2023
The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.
August 17, 2023
Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
August 17, 2023
Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer.
August 16, 2023
Defining aggressive prostate cancer: a geospatial perspective.
August 16, 2023